Sex differences in cardiovascular outcomes of SGLT-2 inhibitors in heart failure randomized controlled trials: A systematic review and meta-analysis

Sex differences in cardiovascular outcomes of SGLT-2 inhibitors in heart failure randomized controlled trials: A systematic review and meta-analysis

Background: In patients with heart failure (HF), randomized controlled trials (RCTs) of sodium-glucose transporter-2 inhibitors (SGLT-2is) have proven to be effective in decreasing the primary composite outcome of cardiovascular death and hospitalizations for HF. A recently published meta-analysis s...

Full description

Bibliographic Details
Main Authors: Frederick Berro Rivera, Vincent Anthony S. Tang, Deogracias Villa De Luna, Edgar V. Lerma, Krishnaswami Vijayaraghavan, Amir Kazory, Nilay S. Shah, Annabelle Santos Volgman
Format: Article
Language:English
Published: Elsevier 2023-02-01
Series:American Heart Journal Plus
Subjects:
SGLT-2 inhibitors
Sex differences
Cardiovascular outcomes
Cardiorenal
Heart failure
Online Access:http://www.sciencedirect.com/science/article/pii/S2666602223000137

Internet

http://www.sciencedirect.com/science/article/pii/S2666602223000137

Similar Items